Disclosure! These peptides have not been evaluated by the FDA. These peptides are not a form of medication and are for research purposes only. Purchasing research peptides for personal use is illegal.
Subscription Cargrilintide
Cargrilintide Cas # 1415456-99-3
Cagrilintide is a long-acting analogue of amylin. It is being tested to treat obesity and type 2 diabetes by itself and in combination with semaglutide as cagrilintide/semaglutide
Lyophilized powder form, intended solely for laboratory use and not for human consumption.
